# US 2017/0255743 A1 · Systems and methods for genomic annotation and distributed variant interpretation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0255743 A1
- Document ID: US20170255743A1
- Status: Published application
- Kind: A1
- Application number: 15/128,924
- Filed: 2015-03-26
- Published: 2017-09-07
- Earliest claimed: 2014-03-27
- Assignees: The Scripps Research Institute
- Applicants: The Scripps Research Institute
- Inventors: Ali Torkamani
- Web page: https://patentgrep.com/patent/US20170255743A1

## CPC

- G16B 20/20: Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
- G16B 20/00: ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B 50/00: ICT programming tools or database systems specially adapted for bioinformatics
- G16B 50/10: Ontologies; Annotations
- G16H 70/60: relating to pathologies
- G16B 20/10: Ploidy or copy number detection
- G16B 20/40: Population genetics; Linkage disequilibrium
- Y02A 90/10: Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

A computer-based genomic annotation system, including a database configured to store genomic data, non-transitory memory configured to store instructions, and at least one processor coupled with the memory, the processor configured to implement the instructions in order to implement an annotation pipeline and at least one module filtering or analysis of the genomic data.

## Claims

### Claim 1

A computer-based genomic annotation system, comprising:
non-transitory memory configured to store instructions, and
at least one processor coupled with the memory, the processor configured to:
receive a variant file including a plurality of variants, wherein at least one of the plurality of variants is a copy number variant;
generate an annotation file containing annotations corresponding to a plurality of predefined annotation categories for each of the plurality of variants; wherein generating the annotation file comprises:
for each variant of the plurality of variants, generating a plurality of annotations corresponding to the plurality of predefined annotation categories, wherein at least one of the plurality of generated annotations indicates a potential functional impact of the copy number variant on at least one known gene; and
populating the annotation file with the plurality of generated annotations.

### Claim 2 (depends on 1)

The computer based genomic annotation system of claim 1, wherein at least one of the plurality of generated annotations indicates the fraction of exon bases of the at least one known gene that are positioned inside the copy number variant, the fraction of exon bases of the at least one known gene that are positioned outside the copy number variant, the fraction of the conserved portion of the at least one known gene that is positioned inside the copy number variant, and/or the fraction of the conserved portion of the at least one known gene that is positioned inside the copy number variant.

### Claim 3 (depends on 1)

The computer based genomic annotation system of claim 1, wherein at least one of the plurality of generated annotations indicates a dosage of the copy number variant provided in the variant file.

### Claim 4 (depends on 1)

The computer based genomic annotation system of claim 1, wherein at least one of the plurality of generated annotations indicates the distance between the copy number variant and the at least one known gene.

### Claim 5 (depends on 1)

The computer based genomic annotation system of claim 1, wherein at least one of the plurality of generated annotations is an ACMG based category.

### Claim 6 (depends on 5)

The computer based genomic annotation system of claim 5, wherein the ACMG based category is based at least in part on the potential functional impact of the copy number variant on the at least one known gene.

### Claim 7

A computer-based genomic annotation system, comprising:
non-transitory memory configured to store instructions, and
at least one processor coupled with the memory, the processor configured to:
receive a variant file including a plurality of variants, wherein at least one of the plurality of variants is a copy number variant;
generate an annotation file containing annotations corresponding to a plurality of predefined annotation categories for each of the plurality of variants; wherein generating the annotation file comprises:
for each variant of the plurality of variants, generating a plurality of annotations corresponding to the plurality of predefined annotation categories, wherein at least one of the plurality of generated annotations indicates the amount of a previously identified copy number variant that overlaps the copy number variant; and
populating the annotation file with the plurality of generated annotations.

### Claim 8 (depends on 7)

The computer based genomic annotation system of claim 7, wherein at least one of the plurality of generated annotations indicates the amount of the copy number variant that overlaps the previously identified copy number variant.

### Claim 9 (depends on 7)

The computer based genomic annotation system of claim 7, wherein at least one of the plurality of generated annotations is an ACMG based category.

### Claim 10 (depends on 9)

The computer based genomic annotation system of claim 9, wherein the ACMG based category is based at least in part on a potential functional impact of the copy number variant on at least one known gene.

### Claim 11 (depends on 9)

The computer based genomic annotation system of claim 9, wherein the ACMG based category is based at least in part on the amount of the previously identified copy number variant that overlaps the copy number variant.

### Claim 12 (depends on 9)

The computer based genomic annotation system of claim 9, wherein the ACMG based category is based at least in part on the amount of the copy number variant that overlaps the copy number variant.

### Claim 13 (depends on 9)

The computer based genomic annotation system of claim 9, wherein at least one of the plurality of generated annotations indicates the dosage of the copy number variant.

### Claim 14 (depends on 13)

The computer based genomic annotation system of claim 13, wherein at least one of the plurality of generated annotations is an ACMG based category.

### Claim 15 (depends on 13)

The computer based genomic annotation system of claim 13, wherein the ACMG based category is based at least in part on the dosage of the copy number variant.

### Claim 16 (depends on 1)

The computer based genomic annotation system of claim 1, wherein at least one of the plurality of generated annotations indicates the distance between the copy number variant and at least one known gene.

### Claim 17

A computer-based genomic annotation system, comprising:
non-transitory memory configured to store instructions, and
at least one processor coupled with the memory, the processor configured to:
receive a variant file including a plurality of variants;
generate an annotation file containing annotations corresponding to a plurality of predefined annotation categories for each of the plurality of variants; wherein generating the annotation file comprises:
for each variant of the plurality of variants, generating a plurality of annotations corresponding to the plurality of predefined annotation categories, wherein at least one of the plurality of generated annotations is an ACMG based category comprising a set of categories into which at least some variants are categorized, wherein the scoring procedure for generating the ACMG based category for a subset of the categories includes matching a subject variant with previously identified variants, evaluating the subject variant allele frequency, and evaluating predicted functional consequences of the subject variant, and wherein the scoring procedure for the subset of the categories has a sensitivity for actual disease causative variants such that no less than 98% of actual disease causative variants categorized with the scoring procedure are assigned to one of the subset of categories; and
populating the annotation file with the plurality of generated annotations.

### Claim 18 (depends on 17)

The computer based genomic annotation system of claim 17, wherein the scoring procedure for the subset of the categories has a specificity for actual disease causative variants such that no less than 68% of non-disease causing variants categorized with the scoring procedure are assigned to a category other than one of the subset of categories.

### Claim 19 (depends on 17)

The computer based genomic annotation system of claim 17, wherein the subset of categories consists of ACMG categories 1, 2, and 3.

### Claim 20

A computer-based genomic annotation system, comprising:
non-transitory memory configured to store instructions, and
at least one processor coupled with the memory, the processor configured to:
receive a variant file including a plurality of variants, wherein at least one of the plurality of variants is a copy number variant;
generate an annotation file containing annotations corresponding to a plurality of predefined annotation categories for each of the plurality of variants; wherein generating the annotation file comprises:
for each variant of the plurality of variants, generating a plurality of annotations corresponding to the plurality of predefined annotation categories, wherein at least one of the plurality of generated annotations is an ACMG based category comprising a set of categories into which at least some variants are categorized, wherein the scoring procedure for generating the ACMG based category for the copy number variant comprises evaluating the amount that a previously identified copy number variant overlaps the copy number variant; and
populating the annotation file with the plurality of generated annotations.

### Claim 21

A method of testing for a genotype to phenotype association, the method comprising:
with at least one processor, selecting a genomic region;
with at least one processor, identifying a set of variant sites associated with the genomic region for a plurality of subjects classified at least in part by at least one phenotype; and
with at least one processor filtering the set of variant sites to select a subset of variant sites for inclusion in a collapsed set, wherein the filtering comprises selecting variant sites from the set characterized by selected ACMG based categories;
with at least one processor, collapsing the subset of variant sites into a collapsed set for statistical analysis; and
with at least one processor, performing a statistical test for a genotype to phenotype association in the plurality of subjects using the collapsed set.

### Claim 22 (depends on 21)

The method of claim 21, wherein the selected ACMG based categories correspond to ACMG categories 1, 2, and 3.

### Claim 23 (depends on 21)

The method of claim 21, wherein the collapsing comprises assigning a first category to a subject if the subject has at least one minor allele associated with the collapsed variant sites, and assigning a second category to a subject if the subject has no minor allele at any of the collapsed variant sites.

### Claim 24 (depends on 21)

The method of claim 21, comprising:
selecting a second genomic region;
repeating the identifying, filtering, collapsing, and performing for the second genomic region.

### Claim 25 (depends on 23)

The method of claim 23, comprising selecting additional genomic regions and repeating the identifying, filtering, collapsing, and performing for each additional genomic region.

### Claim 26

A method of treating subjects with a pharmaceutical comprising:
administering the pharmaceutical to a plurality of subjects;
associating some of the plurality of subjects with a phenotype based at least in part on observed responses of the plurality of subjects to the pharmaceutical;
with at least one processor, selecting a genomic region;
with at least one processor, identifying a set of variant sites associated with the genomic region for a plurality of subjects classified at least in part by at least one phenotype; and
with at least one processor filtering the set of variant sites to select a subset of variant sites for inclusion in a collapsed set, wherein the filtering comprises selecting variant sites from the set that are characterized by selected ACMG based categories;
with at least one processor, collapsing the subset of variant sites into a collapsed set for statistical analysis; and
with at least one processor, performing a statistical test for a genotype to phenotype association in the plurality of subjects using the collapsed set; and
selectively administering the pharmaceutical to the plurality of subjects and/or additional subjects based at least in part on the genotype to phenotype association.

### Claim 27

A method of treating subjects with a pharmaceutical comprising:
testing a subject for a defined genotype, wherein the genotype is defined at least in part by the presence or absence of at least one minor allele at a collapsed set of one or more variant sites, wherein all the variant sites of the collapsed set are associated with one or more selected ACMG based categories;
administering the pharmaceutical to the subject if the subject exhibits the defined genotype.

### Claim 28

A system for testing for a genotype to phenotype association, the system comprising:
at least one processor configured to:
select a genomic region;
identify a set of variant sites associated with the genomic region for a plurality of subjects classified at least in part by at least one phenotype; and
filter the set of variant sites to select a subset of variant sites for inclusion in a collapsed set, wherein the filtering comprises selecting variant sites from the set characterized by selected ACMG based categories;
collapse the subset of variant sites into a collapsed set for statistical analysis; and
perform a statistical test for a genotype to phenotype association in the plurality of subjects using the collapsed set.

### Claim 29 (depends on 28)

The system of claim 28, comprising an annotation database storing at least some variants present at the variant sites with annotations comprising ACMG based categories.

### Claim 30 (depends on 28)

The system of claim 28, wherein the annotation database stores additional annotations for the at least some variants.

### Claim 31 (depends on 30)

The system of claim 30, wherein the annotations comprising ACMG based categories are based at least in part on one or more of the additional annotations.
